Table 2.

Treatment outcome according to CNS1 status and traumatic lumbar puncture with blasts (TLP).

StudyCNS1TLPPvalue
Abbreviations: BFM, Berlin-Frankfurt-Münster; CNS, central nervous system; EFS, event-free survival; SE, standard error; DCLSG, Dutch Childhood Leukemia Study Group; ALL, acute lymphoblastic lymphoma; SJCRH, St. Jude Children’s Research Hospital 
BFM 95 (1995–1999)10  
    No. patients 1605 135  
    % CNS relapse at 5 yr 3.5 < 0.05 
    % 5-yr EFS (SE) 80 (1) 73 (4) 0.003 
DCLSG ALL 7 & 8 (1988–1997)14  
    No. patients 304 62  
    % CNS relapse at 10 yr 4.9 0.24 
    % 10-yr EFS (SE) 72.6 (2.5) 58 (7.6) < 0.01 
SJCRH XI & XII (1984–1991)17  
    No. patients 336 60  
    % CNS relapse at 5 yr 4.3 (1.1) 7.3 (3.5) 0.13 
    % 5-yr EFS (SE) 77 (2) 60 (6) 0.026 
SJCRH XIIIB (1994–1998)15  
    No. patients 145 17  
    % CNS relapse at 5 yr 0.7 (0.7) 0.73 
    % 5-yr EFS (SE) 80.6 (3.3) 82.4 (8.9) 0.67 
StudyCNS1TLPPvalue
Abbreviations: BFM, Berlin-Frankfurt-Münster; CNS, central nervous system; EFS, event-free survival; SE, standard error; DCLSG, Dutch Childhood Leukemia Study Group; ALL, acute lymphoblastic lymphoma; SJCRH, St. Jude Children’s Research Hospital 
BFM 95 (1995–1999)10  
    No. patients 1605 135  
    % CNS relapse at 5 yr 3.5 < 0.05 
    % 5-yr EFS (SE) 80 (1) 73 (4) 0.003 
DCLSG ALL 7 & 8 (1988–1997)14  
    No. patients 304 62  
    % CNS relapse at 10 yr 4.9 0.24 
    % 10-yr EFS (SE) 72.6 (2.5) 58 (7.6) < 0.01 
SJCRH XI & XII (1984–1991)17  
    No. patients 336 60  
    % CNS relapse at 5 yr 4.3 (1.1) 7.3 (3.5) 0.13 
    % 5-yr EFS (SE) 77 (2) 60 (6) 0.026 
SJCRH XIIIB (1994–1998)15  
    No. patients 145 17  
    % CNS relapse at 5 yr 0.7 (0.7) 0.73 
    % 5-yr EFS (SE) 80.6 (3.3) 82.4 (8.9) 0.67 

or Create an Account

Close Modal
Close Modal